AMPH vs CVS · P/E 12, rev $732.0M vs P/E 16, rev $402.07B
Amphastar P (AMPH) versus CVS Health Corp (CVS) — a side-by-side from cached financials, not a winner call.
Amphastar P (AMPH) is a drug manufacturers - specialty & generic company listed on NASDAQ.
CVS Health Corp (CVS) is a healthcare plans company listed on US.
Latest reported AMPH revenue for 2024-12-31 was $732.0M. Net income was $159.5M. Revenue was up 13.6% from 2023-12-31 to 2024-12-31. AMPH currently screens at market cap $880.1M and trailing P/E 12.0.
Latest reported CVS revenue for 2025-12-31 was $402.07B. Net income was $1.77B. Revenue was up 7.8% from 2024-12-31 to 2025-12-31. CVS currently screens at market cap $86.20B and trailing P/E 16.3.
AMPH currently screens at market cap $880.1M and trailing P/E 12.0. CVS currently screens at market cap $86.20B and trailing P/E 16.3.
Not investment advice. Open the AMPH and CVS stock pages for the full models.
Not investment advice.